PharmaCyte Biotech, Inc. (PMCB)

Company Overview
Nuvilex is an innovative company which aims at ionitiating a paradigm shift, generating revenue at the same time as creating cancer and other cell related solutions to treat important human diseases, such as pancreatic cancer while retaining our connections to natural products. The present effort underway will give rise to dramatic advances in cancer therapy and benefit millions of people worldwid
read more

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Apr 27, 2015

Hotstocked Precision will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 01:35AM EDT April 27, 2015
$ 0.165   0 (1.85%)
Today's Open: 0.1608 Previous Close: 0.162
Today's High: 0.1698 Volume: 3,218,084
Today's Low: 0.16 Avg Vol: 6,465,911
52 Week High: 0.3399 Bid (size): 0
52 Week Low: 0.095 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: Meadows Corporate Park I, 12510 Prosperity Boulevard, Silver Spring, MD 20904, United States
Mailing Address: -
Phone: 240-696-6859
Fax: -
Website: http//www.nuvilex.com

Company Details:

Symbol: PMCB
SIC: -
State location: MD
Sector: -
State of Inc: NV
Employees: 1
Type: -

Key executives:

Name Age Position
2015
Dr. Gerald W. Crabtree 2015 COO
Patricia Gruden 2015 Chairman of the Board of Directors and CFO
Robert F. Ryan 2015 President, CEO

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Apr 27, 2015

This free program will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Roller Coaster Continues April 22, 2015

The pullback that PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) is going through continued in yesterday's session. The stock slid over 10% on share volume that was dramatically faded compared to the previous sessions. PMCB stopped at $0.16 per share by the cl... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Steps on the Brakes April 20, 2015

After an impressive green run, on Friday the stock of PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) turned red once more. The price hike up the chart continued for a short while in the morning but PMCB ultimately stopped 6% down by the bell, at $0.204 per sha... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Moves Up, Gets New Pumps April 16, 2015

Yesterday's session propelled PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) up the charts once again. The stock had already shot up by a quarter before this last jump. PMCB stopped at $0.173 per share by the closing bell, after shifting a total of 9 million s... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Soars on Medical Article April 14, 2015

After a morning press release on Friday, the stock of PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) took off sharply and ended the session over 10% in the green. Another followup PR helped drive PMCB stock even higher, as the price climbed another 8.2% yester... read more

LATEST STOCK PROMOTIONS

PMCB - Huge BUY signal just triggered! Details Inside Apr 22, 2015, 22:15

      OTCtipReporter.com         Reports Wall Street's Top Emerging Growth Companies!                  PMCB Is On Immediate ALERT! Dear Fellow Trader. My New BIG Report is PMCB PharmaCyte Biotech, Inc. (OTCQB: PMCB) Technical indicators are signaling breakout gain potential! The experts read more

Promoter: OTC tip Reporter Paying Party: Cream Consulting Max Profit: 0.82% Gain at close: Pending
Stock: pmcb Compensation: $7,500 Avg $ Volume for Period: UNKNOWN

PMCB - Is On Immediate ALERT! Apr 22, 2015, 20:44

  PMCB Is On Immediate ALERT! Dear Fellow Trader, My New BIG Report is PMCB PharmaCyte Biotech, Inc. (OTCQB: PMCB) Imagine a breakthrough so powerful that it could forever change the way your cells fight cancer or diabetes. Our New Pick Is PMCB - PharmaCyte Biotech's patented breakthrough Cell-in-a-Box technology encapsulates live cells in a kind of cocoon in order to activate delivery of targeted treatments read more

Promoter: MicroCapProfiler1 Paying Party: Cream Consulting Max Profit: 0.82% Gain at close: Pending
Stock: pmcb Compensation: $7,500 Avg $ Volume for Period: UNKNOWN

PMCB - Is On Immediate ALERT! Apr 22, 2015, 20:33

        4/22/2015 EQUITYTRADINGALERT.COM PMCB Is On Immediate ALERT!                                                       Dear Fellow Trader, My New BIG Report read more

Promoter: EquityTradingAlert.com Paying Party: Cream Consulting Max Profit: 0.82% Gain at close: Pending
Stock: pmcb Compensation: $7,500 Avg $ Volume for Period: UNKNOWN

Nuvilex, Inc. (NVLX) MESSAGE BOARD

Post # Subject Re Name Date
1 Such a deep anewsr! GD&RVVF 0
2 I love these areltics. How many words can... 0
3 Well, I think the Fed has to do a lot... 0
4 I just love how optimistic Jim Cramer and... 0
5 Dear Minamar,Can you give me some more... 0
6 Well mamiadcaa nuts, how about that. 0
7 I hope so 0
8 I'm a Dollarniare now! The scams on otc... 0
9 yes we are ging to be millionaires but it... 1
10 chemo kills weed does not 0
11 What happened to this stock today? It's... 0
12 Oh what happened? 2
13 Tanking like a ROCK!! Alpha Articles out!!! 4
14 FDA possible approval response to NVLX... 1
15 Yes it can 0
16 Man! I'd personally write some options... 0
17 20 Ducats? You jest my dear buffoon! 0
18 Oh Sheeheeheeheet! NVLX is fo' real ?... 0
19 50:1 split? Ha ha 0
20 with a 50:1 Reverse stock split! Yes... 0